share_log

PRESS DIGEST- Financial Times - July 28

PRESS DIGEST- Financial Times - July 28

新聞摘要-《金融時報》7 月 28 日
路透社 ·  2020/07/28 09:16

July 28 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
  
   Headlines
  
   - Moderna begins first late-stage U.S. trial of COVID-19 vaccine  
  
   - Intel engineering executive leaves in leadership shake-up 
  
   - Nike diversity chief leaves after two years in role
  
  
   Overview
  
   - Moderna Inc has given the first doses of its experimental COVID-19 vaccine to participants in what will be a 30,000-person trial, as the U.S. moved into a new phase in the race to develop a vaccine by the start of next year.
  
   - Intel Corp announced several management changes on Monday which include the departure of Murthy Renduchintala, who had been in charge of the U.S. chipmaker's manufacturing, engineering and technology, following setbacks in its advanced manufacturing development.
  
   - Nike Inc's director of diversity and inclusion Kellie Leonard, is stepping down after just two years in the role, according to an email to Nike staff in which chief executive officer John Donahoe called the moves "a structural shift".
  
  

(Compiled by Bengaluru newsroom)
((globalnewsmonitoring@thomsonreuters.com)

7 月 28 日(路透社)-以下是《金融時報》的重要故事。路透社尚未驗證這些故事,也不能保證其準確性。

標題

-現代開始美國首次 COVID-19 疫苗的後期試驗

-英特爾工程主管離開了領導力的動搖

-耐克多樣性首席在擔任兩年後離開
  

概述

-隨著美國在明年初開始進入比賽中進入了新階段,Moderna Inc 已向參與者提供了其實驗性 COVID-19 疫苗的第一劑試驗,這將是三萬人試驗。

-英特爾公司週一宣布了幾項管理變更,其中包括 Murthy Renduchintala 的離職,他一直負責美國晶片製造商的製造、工程和技術,在其先進製造開發方面遇到挫折。

-耐克公司的多樣性和包容性的董事凱利·倫納德,在短短兩年的角色後下台,根據一封電子郵件給耐克的工作人員,其中首席執行官約翰·唐納霍(John Donahoe)稱這一舉動為「結構性轉變」。



(由班加羅爾新聞編輯室編譯)
(globalnewsmonitoring@thomsonreuters.com)

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論